Grant Hill
Insider
First SEC filing: Feb. 3, 2021 · Latest: June 30, 2025
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 25, 2026 | CPB | A | 3,691 | · | · | 43,378 Direct | +9.30% | Acquired | (price as of 2026-10-05) |
| June 29, 2026 | CPB | A | 3,107 | · | · | 39,011 Direct | +8.65% | Acquired | (price as of 2026-10-05) |
| May 15, 2026 | ESRT | A | 23,856 | · | · | 173,692 Direct | +15.92% | Acquired | (price as of 2026-10-05) |
| May 15, 2026 | ESRT | A | 19,236 | · | · | 192,928 Direct | +11.07% | Acquired | (price as of 2026-10-05) |
| March 30, 2026 | CPB | A | 3,224 | · | · | 35,244 Direct | +10.07% | Acquired | (price as of 2026-10-05) |
| Dec. 29, 2025 | CPB | A | 2,540 | · | · | 31,582 Direct | +8.75% | Acquired | (price as of 2026-10-05) |
| Sept. 25, 2025 | CPB | A | 2,220 | · | · | 28,668 Direct | +8.39% | Acquired | (price as of 2026-10-05) |
| June 26, 2025 | CPB | A | 2,309 | · | · | 26,134 Direct | +9.69% | Acquired | (price as of 2026-10-05) |
| May 16, 2025 | ESRT | A | 16,484 | · | · | 136,484 Direct | +13.74% | Acquired | (price as of 2026-10-05) |
| May 16, 2025 | ESRT | A | 13,352 | · | · | 149,836 Direct | +9.78% | Acquired | (price as of 2026-10-05) |
| March 27, 2025 | CPB | A | 1,806 | · | · | 23,573 Direct | +8.30% | Acquired | (price as of 2026-10-05) |
| Dec. 30, 2024 | CPB | A | 1,666 | · | · | 21,558 Direct | +8.38% | Acquired | (price as of 2026-10-05) |
| Sept. 26, 2024 | CPB | A | 1,396 | · | · | 19,739 Direct | +7.61% | Acquired | (price as of 2026-10-05) |
| June 26, 2024 | CPB | A | 1,512 | · | · | 18,199 Direct | +9.06% | Acquired | (price as of 2026-10-05) |
| May 10, 2024 | ESRT | A | 13,408 | · | · | 109,140 Direct | +14.01% | Acquired | (price as of 2026-10-05) |
| May 10, 2024 | ESRT | A | 10,860 | · | · | 120,000 Direct | +9.95% | Acquired | (price as of 2026-10-05) |
| March 27, 2024 | CPB | A | 1,566 | · | · | 16,551 Direct | +10.45% | Acquired | (price as of 2026-10-05) |
| Dec. 28, 2023 | CPB | A | 1,576 | · | · | 14,862 Direct | +11.86% | Acquired | (price as of 2026-10-05) |
| Sept. 29, 2023 | CPB | A | 1,642 | · | · | 13,166 Direct | +14.25% | Acquired | (price as of 2026-10-05) |
| June 29, 2023 | CPB | A | 1,490 | · | · | 11,433 Direct | +14.99% | Acquired | (price as of 2026-10-05) |
| May 12, 2023 | ESRT | A | 23,232 | · | · | 76,924 Direct | +43.27% | Acquired | (price as of 2026-10-05) |
| May 12, 2023 | ESRT | A | 18,808 | · | · | 95,732 Direct | +24.45% | Acquired | (price as of 2026-10-05) |
| March 30, 2023 | CPB | A | 1,245 | · | · | 9,876 Direct | +14.42% | Acquired | (price as of 2026-10-05) |
| Dec. 29, 2022 | CPB | A | 1,162 | · | · | 8,570 Direct | +15.69% | Acquired | (price as of 2026-10-05) |
| Sept. 29, 2022 | CPB | A | 1,401 | · | · | 7,357 Direct | +23.52% | Acquired | (price as of 2026-10-05) |
| June 29, 2022 | CPB | A | 1,361 | · | · | 5,912 Direct | +29.91% | Acquired | (price as of 2026-10-05) |
| May 13, 2022 | ESRT | A | 16,156 | · | · | 40,871 Direct | +65.37% | Acquired | (price as of 2026-10-05) |
| May 13, 2022 | ESRT | A | 12,821 | · | · | 53,692 Direct | +31.37% | Acquired | (price as of 2026-10-05) |
| March 30, 2022 | CPB | A | 1,494 | · | · | 4,516 Direct | +49.44% | Acquired | (price as of 2026-10-05) |
| Dec. 30, 2021 | CPB | A | 836 | · | · | 2,997 Direct | +38.69% | Acquired | (price as of 2026-10-05) |
| Sept. 30, 2021 | CPB | A | 843 | · | · | 2,141 Direct | +64.95% | Acquired | (price as of 2026-10-05) |
| June 30, 2021 | CPB | A | 792 | · | · | 1,288 Direct | +159.68% | Acquired | (price as of 2026-10-05) |
| June 1, 2021 | ESRT | A | 10,516 | · | · | 16,391 Direct | +179.00% | Acquired | (price as of 2026-10-05) |
| June 1, 2021 | ESRT | A | 8,324 | · | · | 24,715 Direct | +50.78% | Acquired | (price as of 2026-10-05) |
| March 31, 2021 | CPB | A | 492 | · | · | 492 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 3, 2020 | ESRT | A | 5,875 | · | · | 5,875 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 23,856 | Acquired |
| May 15, 2026 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 19,236 | Acquired |
| May 16, 2025 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 16,484 | Acquired |
| May 16, 2025 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 13,352 | Acquired |
| May 10, 2024 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 13,408 | Acquired |
| May 10, 2024 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 10,860 | Acquired |
| May 12, 2023 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 23,232 | Acquired |
| May 12, 2023 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 18,808 | Acquired |
| May 13, 2022 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 16,156 | Acquired |
| May 13, 2022 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 12,821 | Acquired |
| June 1, 2021 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 10,516 | Acquired |
| June 1, 2021 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 8,324 | Acquired |
| Dec. 3, 2020 | ESRT | LTIP Units [F1] | Class A Common Stock | · | · | 5,875 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.